Empiric Trial

From Ask Dr Wiki

Jump to: navigation, search

Contents

Introduction

The hypothesis of the Empiric Trial was that a empiric set of VT/VF programmable settings is at least as effective as physician tailored choices as measured by the shock related morbidity of ICD therapy. The endpoints were the proportion of true VT/VF episodes that were shocked and the Proportion of true SVT episodes that were inappropriately shocked. The settings programmed in the Empiric arm are listed below

Empiric Arm Programming

ZoneDetectionInterval/RateBeats to DetectTherapies
VFOn300 ms (>200 bpm)18 of 24 30J x 6
FVTVia VF240ms (201 - 250 bpm)NABurst3, 30 J x 5
VTOn>400ms (<150-200 bpm)16Burst1, Burst2, Ramp1, 20J, 30 J x 3
  • PR LogicĀ® Detection On: AF/Afl
  • Sinus Tach (1:1 VT-ST = 66%)
  • SVT Limit = 300 ms
  • Burst1, ATP: 8 intervals, R-S1 = 88%, 20 ms decrement
  • Burst2, ATP: 8 intervals, R-S1 = 88%, 20 ms decrement
  • Ramp1, ATP: 8 intervals, R-S1 = 81%, 10 ms decrement
  • Burst3, ATP: 8 intervals, R-S1 = 88%, 10 ms decrement

Results

The adjusted percentages of VT/VF that were shocked was 22.3% in the Empiric Group and 28.7% in the physician tailored group. The percentage of supraventricular tachycardia or other non-VT/VF event episodes that resulted in a shock were was 11.9% vs. 26.1% in the Empiric arm compared to the Tailored arm. There were no significant differences in total mortality, syncope, emergency room visits, or unscheduled outpatient visits. Unscheduled hospitalizations occurred significantly less often (p = 0.001) in the Empiric arm.

Conclusions

Standardized empiric ICD programming for VT/VF settings is at least as effective as patient-specific, physician-tailored programming, as measured by many clinical outcomes.

References

A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol. 2006 Jul 18;48(2):330-9. Epub 2006 Jun 22.

Personal tools